Surface Low-Grade Cartilage Malignancy
- PERIOSTEAL (juxtacortical) CHONDROSARCOMA is a rare malignant CARTILAGE tumour arising on the bone SURFACE (from the periosteum/cortex) rather than within the medullary cavity; according to PubMed it most often involves the METAPHYSIS of the long bones of the extremities, and the great majority are LOW (and some intermediate) grade.
- It exhibits a LOW-GRADE, generally INDOLENT biological behaviour with a GOOD prognosis: in a large referral-centre series, local recurrence and lung metastasis were uncommon and survival was good, and clinical/morphological parameters did not reliably predict outcome - the few patients who developed metastases died, but these were the minority.
- A proportion of periosteal chondrosarcomas harbour IDH1 mutations (as in other cartilage tumours), which can support the diagnosis on molecular testing; the lesion shows a chondroid (cartilage) matrix on imaging, with cortical scalloping/thickening and a surface soft-tissue mass.
- The key DIFFERENTIAL is from the benign PERIOSTEAL CHONDROMA (a small, benign surface cartilage tumour, usually a few centimetres) and from PERIOSTEAL (surface) OSTEOSARCOMA - distinction rests on size and aggressiveness, the matrix (chondroid in chondrosarcoma vs osteoid in osteosarcoma), and the histological grade; a periosteal chondroma that is large or aggressive should raise concern for chondrosarcoma.
- DIAGNOSIS requires imaging (radiograph/CT for the chondroid matrix and cortical changes, MRI for extent) and a properly PLANNED BIOPSY read at a specialist centre, with staging where indicated; as with all bone sarcomas, an unplanned excision must be avoided.
- MANAGEMENT of (the usual low-grade) periosteal chondrosarcoma is adequate surgical EXCISION - according to PubMed, the low-grade behaviour can be adequately treated with MARGINAL excision (wide excision for higher-grade) - and, like other low/intermediate-grade chondrosarcomas, it is relatively CHEMO/RADIO-RESISTANT, so surgery is the mainstay; the rare high-grade/dedifferentiated lesions are treated more aggressively.
- “Periosteal chondrosarcoma = rare SURFACE (juxtacortical) malignant cartilage tumour, usually LOW-grade, at the METAPHYSIS of long bones. Chondroid matrix; cortical scalloping; IDH1 in a proportion.
- “Low-grade/indolent with GOOD prognosis; local recurrence/metastasis uncommon (high-grade/dedifferentiated lesions are the dangerous minority).
- “Differential: benign periosteal chondroma (small) vs surface osteosarcoma (osteoid matrix). Treatment = adequate EXCISION (marginal for low-grade; wide for higher-grade); chondrosarcomas are chemo/radio-resistant.
A surface (juxtacortical) cartilage lesion at the metaphysis of a long bone, with chondroid matrix and cortical changes = periosteal chondrosarcoma (usually low-grade, good prognosis).
Benign periosteal chondroma (small) vs periosteal chondrosarcoma (larger/aggressive) vs surface osteosarcoma (osteoid matrix). Grade on a planned biopsy.
Features, Differential & Management
Periosteal chondrosarcoma is a rare surface (juxtacortical) malignant cartilage tumour, arising on the bone surface, usually at the metaphysis of a long bone, and the great majority are low/intermediate grade with indolent behaviour and a good prognosis. It shows a chondroid matrix with cortical scalloping/ buttressing, and a proportion carry IDH1 mutations. It must be distinguished from the benign periosteal chondroma (small) and from surface osteosarcoma (osteoid matrix). Diagnosis uses imaging plus a planned biopsy at a specialist centre; management is adequate excision - marginal for low-grade, wide for higher-grade - and, as cartilage tumours are chemo/radio-resistant, surgery is the mainstay.
| Lesion | Nature | Key features |
|---|---|---|
| Periosteal chondroma | Benign | Small (usually a few cm) surface cartilage tumour; saucerised cortex |
| Periosteal chondrosarcoma | Malignant (usually low-grade) | Larger, metaphyseal, chondroid matrix, cortical scalloping; IDH1 in a proportion |
| Periosteal osteosarcoma | Malignant (intermediate-grade) | Diaphyseal, chondroblastic but osteoid-producing |
Periosteal chondrosarcoma is, in the great majority of cases, a low-grade surface malignancy that behaves indolently and is cured by adequate surgical excision - marginal excision for low-grade lesions, with wider margins for the uncommon higher-grade tumours - and, because cartilage tumours are relatively resistant to chemotherapy and radiotherapy, surgery is the mainstay. The pitfalls are diagnostic. A benign periosteal chondroma that is large or behaves aggressively should raise concern for chondrosarcoma, and a surface lesion that produces osteoid is a surface osteosarcoma, not a chondrosarcoma - so the diagnosis and grade must be established on a properly planned biopsy read at a specialist centre, with appropriate imaging and staging, before definitive surgery. As with all bone sarcomas, an unplanned excision of an undiagnosed surface mass compromises the eventual oncological result.
Evidence & Key Studies
Periosteal chondrosarcoma: a case series with survivorship analysis
- In 55 periosteal chondrosarcomas (median age 37, male predominance), the great majority involved the metaphysis of long bones of the extremities; most were grade 1-2 (low/intermediate), with a minority grade 3 or dedifferentiated.
- Around a third of cases tested harboured IDH1 mutations; over long follow-up (median 137 months) local recurrence (4) and lung metastasis (6) were uncommon, and all patients who metastasised died of disease while most remained alive without disease.
- Periosteal chondrosarcomas exhibit a low-grade behaviour that can be adequately treated with marginal excision, and clinical/morphological parameters did not reliably predict outcome.
According to PubMed, the metaphyseal long-bone location, the predominantly low/intermediate grade with indolent behaviour and good prognosis (uncommon recurrence/metastasis), the IDH1 mutation in a proportion, and the adequacy of marginal excision for low-grade lesions come from the cited Pacheco series. The distinction from benign periosteal chondroma and from surface osteosarcoma, the chemo/radio-resistance of cartilage tumours, and the biopsy/staging principles are standard, well-established teaching. (See also our Chondrosarcoma, Enchondroma/ Periosteal Chondroma and High-Grade Surface Osteosarcoma topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“How do you approach a surface cartilage lesion at the metaphysis of the femur reported as a possible periosteal chondrosarcoma?”
Mnemonics & Memory Aids
CHONDRAL
Hook:CHONDRAL: Cartilage matrix, differential (chondroma/sarcoma/osteosarcoma), Often low-grade, Near metaphysis, Diagnose+grade, Resect, chemo/radio-resistant.
What it is
- Rare surface (juxtacortical) malignant cartilage tumour
- Usually low/intermediate grade; metaphysis of long bones
- Chondroid matrix + cortical scalloping; IDH1 in a proportion
Behaviour & differential
- Indolent/low-grade; good prognosis (recurrence/metastasis uncommon)
- Differential: benign periosteal chondroma (small); surface osteosarcoma (osteoid)
- High-grade/dedifferentiated lesions = the dangerous minority
Management
- Planned biopsy + grade at a sarcoma unit; stage as indicated
- Adequate excision (marginal for low-grade; wide for higher-grade)
- Cartilage tumours chemo/radio-resistant - surgery is the mainstay